Aurinia Pharmaceuticals Inc. of VICTORIA, A1, a company, filed a Form D exempt-offering notice with the SEC on 2014-02-28. The offering totals $52.0M, of which $52.0M was reported sold. Industry: Biotechnology.
| Name | Role | Location |
|---|---|---|
| Kurt von M Emster | Director | Victoria, A1 |
| Richard M Glickman | Director | Victoria, A1 |
| Chris M Kim | Director | Victoria, A1 |
| Michael M Martin | Director | Victoria, A1 |
| Daniel M Park | Director | Victoria, A1 |
| Benjamin M Rovinski | Director | Victoria, A1 |
| Peter M Wijngaard | Director | Victoria, A1 |
| Donald M Wyatt | Director | Victoria, A1 |
| Stephen W Zaruby | Director | Victoria, A1 |
| Dennis M Bourgeault | Executive Officer | Victoria, A1 |
| Richard M Glickman | Executive Officer | Victoria, A1 |
| Michael M Martin | Executive Officer | Victoria, A1 |
| Stephen W Zaruby | Executive Officer | Victoria, A1 |